BIO KEY INTERNATIONAL INC

BIO-key International, Inc. is a provider of identity and access management (IAM) platform solutions, enabling secure multi-factor authentication (MFA) for enterprise, education, and government customers. The company operates in the biometric technology and identity access management industries, with its products addressing the need for secure work-from-anywhere environments. The filing does not disclose specific market size or growth rates for the industry.

The filing does not name specific primary competitors or provide market share data. However, the company states it is a 'leading identity and access management (IAM) platform provider' and that its technology is used in 'some of the largest biometric systems in the world.' The filing also notes that BIO-key's products are designed to address gaps in mainstream MFA approaches, such as authenticating users who rove among workstations and preventing unauthorized account sharing.

BIO-key generates revenue through a combination of SaaS term licenses, hardware sales, and services. The company sells multi-year subscriptions to its software, generating annual recurring revenue (ARR). Revenue is derived from three primary sources: services, licenses, and hardware. In 2025, hardware products generated 22% of revenue, compared to 9% in 2024. The company sells directly through field and inside sales teams and indirectly through a network of channel partners, including more than 85 resellers, system integrators, and distributors. Customer segments include enterprise, education, government, and highly regulated industries such as healthcare and financial services.

BIO-key's primary product lines include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS), which provide MFA, Single Sign On (SSO), and Self-Service Password Reset (SSPR) capabilities. PortalGuard can operate as a standalone solution or as an upgraded MFA experience within enterprise IAM frameworks such as Microsoft, Okta, Ping, or ForgeRock. The company also offers WEB-key, a scalable biometric service management platform for large-scale civil ID projects, supporting over 30 fingerprint scanners interchangeably. Additional products include MobileAuth, a mobile phone authentication application for iOS and Android, and a line of fingerprint scanners such as the PIV Pro, SidePass, EcoID II, SideSwipe, and the newly introduced EcoID III, which is PIV-071006 FAP-20 compliant. The filing does not provide specific revenue or margin figures for individual product lines.

The filing does not provide a separate product line breakdown beyond the categories of services, licenses, and hardware. Hardware products generated 22% of revenue in 2025 and 9% in 2024. The filing does not disclose specific revenue or margin figures for services or licenses individually.

On November 27, 2024, BIO-key commenced a collaboration with Fiber Food Systems, Inc., an early-stage company focused on global food security solutions, and acquired shares of Boumarang, Inc. from Fiber. Boumarang is developing sustainable, AI-driven, hydrogen-powered, long-range drone technology, and BIO-key is working to integrate its biometric technology into autonomous systems. On March 8, 2022, the company expanded into Europe, Africa, and the Middle East by acquiring Swivel Secure Europe, SA, a Madrid-based provider of IAM solutions serving over 300 customers through a network of dozens of channel partners. On June 30, 2020, BIO-key acquired PistolStar, Inc., which provides enterprise-ready IAM solutions and develops the PortalGuard line of software and services. The filing does not disclose specific dollar amounts for these acquisitions or any share repurchase, debt redemption, or new facility events during the period.

For the fiscal year ended December 31, 2025, BIO-key reported total revenue of $4,100,000 ¹, compared to $4,100,000 ² in the prior year, indicating flat revenue. The company reported a net loss of $3,500,000 ³ for 2025, compared to a net loss of $3,200,000 ⁴ in 2024. The filing does not provide a breakdown of revenue growth or contraction by segment, nor does it discuss margin trends or cash generation in the summary narrative.

The filing identifies several growth vectors. The company is prioritizing securing agreements with OEM customers, building on an established footprint with customers such as NCR, Omnicell, and Idemia. The filing notes that OEM customers' ordering patterns are more predictable and require lower service and support resourcing. Additionally, the company sees strong opportunity in highly regulated industries, including government ID projects, healthcare organizations, and the financial services industry. The company also expects to continue to pursue strategic acquisitions of select businesses and assets in the IAM space, though it provides no assurance of completing any acquisition. The filing does not quantify the opportunity size or expected revenue contribution for these vectors.

The filing does not discuss margin trajectory, cost structure evolution, or efficiency or restructuring targets with specific figures.

The filing does not discuss supply chain posture, manufacturing capacity, technology infrastructure investments, or headcount or workforce strategy with specific figures.

The filing does not disclose specific R&D spending levels, capital expenditure plans, share repurchase authorization amounts, or dividend policy figures.

The filing does not explicitly flag structural headwinds or execution risks to the growth plan in a dedicated section, though risk factors are discussed elsewhere.

The filing does not identify geographic, regulatory, or macro factors as constraints in a dedicated outlook section.

BIO-key faces material risks including its history of losses and limited revenue, as evidenced by a net loss of $3,500,000 in 2025 and $3,200,000 in 2024. The company's ability to continue as a going concern is a stated risk. Customer concentration is a significant risk: in 2025, two customers accounted for 100% of subscription order revenue, and two customers represented 100% of accounts receivable. In 2024, one customer accounted for 100% of subscription order revenue, and two customers represented 100% of accounts receivable. The company also faces risks related to its ability to raise additional capital, protect intellectual property, and compete in the biometric technology and identity access management industries. The filing identifies nation state-sponsored threat actors and the rise in sophistication and proliferation of ransomware campaigns as top reasonable material risks to the business, though to date there have not been any risks that have materially affected operations.

Management's message emphasizes the company's vision to enable any organization to secure streamlined and passwordless workforce, customer, citizen, and student access. Key strategic priorities include growing the Channel Alliance Partner program, which has partnered with more than 85 resellers, system integrators, and other distribution partners, and continuing to pursue strategic acquisitions.